Panacea Biotec Ltd reports Q2 FY27 consolidated net profit of ₹11.91 crore, versus a ₹14.01 crore loss a year earlier
- Revenue was ₹189.67 crore, up 34.4% year on year and down 5.0% sequentially.
- Net profit included ₹2.77 crore of exceptional income; Q1 FY27 profit was ₹2.20 crore.
- Board approved unaudited results for the quarter and half-year ended September 30, 2026; limited-review reports carried unmodified conclusions, with a going-concern uncertainty noted for the standalone company.
